Takeda Pharmaceutical »

Lyell Immunopharma shares owned by Takeda Pharmaceutical

Quarter-by-quarter ownership of Lyell Immunopharma shares owned by Takeda Pharmaceutical from 13F filings

Historical chart of Takeda Pharmaceutical investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Takeda Pharmaceutical consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Takeda Pharmaceutical

Quarter filed Position value Share count Share price at filing
2025-09-30 $891k 55k 16.24
2025-06-30 $364k 41k 8.84
2025-03-31 $443k 823k 0.54

More positions owned by Takeda Pharmaceutical

Ovid Therapeutics (OVID)
Equillium (EQ)
Xilio Therapeutics (XLO)
Shattuck Labs (STTK)
Lyell Immunopharma
American Well Corp-class A (AMWL)
Rani Therapeutics Hldgs (RANI)
D Fluidigm Corp Del (LAB)

View all positions for Takeda Pharmaceutical

Top funds holding Lyell Immunopharma

Decheng Capital
Takeda Pharmaceutical

View all funds holding Lyell Immunopharma